Literature DB >> 30660941

Neurodevelopmental outcomes at five years after early-onset fetal growth restriction: Analyses in a Dutch subgroup participating in a European management trial.

A Pels1, O C Knaven2, B J Wijnberg-Williams3, M J C Eijsermans4, S M Mulder-de Tollenaer3, C S H Aarnoudse-Moens5, C Koopman-Esseboom4, J van Eyck6, J B Derks7, W Ganzevoort2, A G van Wassenaer-Leemhuis5.   

Abstract

OBJECTIVE: The objective of this study is to explore developmental outcomes at five years after early-onset fetal growth restriction (FGR). STUDY
DESIGN: Retrospective data analysis of prospective follow-up of patients of three Dutch centres, who participated in a twenty centre European randomized controlled trial on timing of delivery in early-onset FGR. Developmental outcome of very preterm infants born after extreme FGR is assessed at (corrected) age of five.
RESULTS: Seventy-four very preterm FGR children underwent follow-up at the age of five. Mean gestational age at birth was 30 weeks and birth weight was 910 g, 7% had a Bayley score <85 at two years. Median five years' FSIQ was 97, 16% had a FSIQ < 85, and 35% had one or more IQ scores <85. Motor score ≤ 7 on movement ABC-II (M-ABC-II-NL) was seen in 38%. Absent or reversed end-diastolic flow, gestational age at delivery, birthweight and neonatal morbidity were related to an FSIQ < 85. Any abnormal IQ scale score was related to birthweight, male sex and severity of FGR, and abnormal motor score to male sex and bronchopulmonary dysplasia (BPD).
CONCLUSIONS: Overall, median cognitive outcome at five years was within normal range, but 35% of the children had any abnormal IQ score at age five, depending on the IQ measure, and motor impairment was seen in 38% of the children. GA at delivery, birthweight, EDF prior to delivery and neonatal morbidity were the most important risk factors for cognitive outcomes.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Fetal growth retardation; IQ; Long term follow-up; Neurodevelopmental outcome; Pregnancy outcome

Mesh:

Year:  2019        PMID: 30660941     DOI: 10.1016/j.ejogrb.2018.12.041

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  3 in total

1.  Short-term outcomes of phosphodiesterase type 5 inhibitors for fetal growth restriction: a study protocol for a systematic review with individual participant data meta-analysis, aggregate meta-analysis, and trial sequential analysis.

Authors:  Jessica Liauw; Katie Groom; Wessel Ganzevoort; Christian Gluud; Christopher J D McKinlay; Andrew Sharp; Laura Mackay; Chirag Kariya; Ken Lim; Peter von Dadelszen; Jacqueline Limpens; Janus C Jakobsen
Journal:  Syst Rev       Date:  2021-12-03

2.  Associations of severe adverse perinatal outcomes among continuous birth weight percentiles on different birth weight charts: a secondary analysis of a cluster randomized trial.

Authors:  Hester D Kamphof; Sanne J Gordijn; Wessel Ganzevoort; Viki Verfaille; Pien M Offerhaus; Arie Franx; Eva Pajkrt; Ank de Jonge; Jens Henrichs
Journal:  BMC Pregnancy Childbirth       Date:  2022-04-30       Impact factor: 3.105

3.  Placental expression of estrogen-related receptor gamma is reduced in fetal growth restriction pregnancies and is mediated by hypoxia†.

Authors:  Zhiyong Zou; Lynda K Harris; Karen Forbes; Alexander E P Heazell
Journal:  Biol Reprod       Date:  2022-09-12       Impact factor: 4.161

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.